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Achromobacter spp. may contaminate lenses, lens cases, and contact lens
solutions and cause ocular infections. The aim of this study was to investigate the
possibility of isolated strain of Achromobacter xylosoxidans to form bioﬁlm on the
surface of soft contact lenses (CL), to quantify the production of the formed bioﬁlm,
and compare it with the reference strains (Pseudomonas aeruginosa, Staphylococcus
aureus, and Haemophilus inﬂuenzae). Bacterial strain isolated from one contact lens
case was identiﬁed as A. xylosoxidans using Vitek2 Automated System. Bioﬁlm
forming capacity of isolated strain of A. xylosoxidans and reference strains of
P. aeruginosa, S. aureus, and H. inﬂuenzae on soft CL were analyzed by commonly
used microtitre plate method. Our results showed that isolated strain of A. xylosoxidans
was capable to form bioﬁlm on the surface of soft contact lens. A. xylosoxidans was
strong bioﬁlm producer while all examined reference strains were moderate bioﬁlm
producers. A. xylosoxidans appears to be superior bioﬁlm producer on soft CL
compared to reference strains.
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Introduction
Bioﬁlms are composed of bacterial cells attached to biotic or abiotic surfaces
and encased in a complex, self-secreted polymeric matrix. Bacteria in a bioﬁlm
differ from planktonic cells, in having an increased resistance to antimicrobials
and the host immune defence [1].
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The presence of bacterial bioﬁlms has been demonstrated on many medical
devices such as urinary catheters, intrauterine devices, ventricular assist devices,
neurosurgical ventricular shunts, prosthetic heart valves, intravascular catheters,
coronary stents, prosthetic joint, cochlear implants, intraocular and contact
lenses (CL) [1, 2]. Since CL are increasingly being used, they became one of
the main predisposing risk factors for infectious keratitis [3, 4]. Integrity of the
epithelial surface of cornea is compromised by the interactions of lens and ocular
surface, which increases the ability of microbes to adhere and cause an infection
in healthy host [5]. Also, the presence of bioﬁlm on the contact lens may increase
potential pathogenicity of bacteria, by prolonging their retention time at
the ocular surface [6]. It is documented that bioﬁlm present on lenses or lens
cases shows enhanced resistance to the antimicrobial activities of contact lens
solutions [7].
Pseudomonas aeruginosa is documented as the most common causative
agent of infections related to contact lens wear, and Serratia marcescens,
Staphylococcus aureus, Acanthamoeba spp., and Fusarium spp. as following
major causative pathogens [8]. The ability of P. aeruginosa, S. marcescens,
and S. aureus to form bioﬁlms on CL is well documented in the literature [2, 7].
Achromobacter xylosoxidans is a closely related bacterium to
Pseudomonas spp. – aerobic, non-glucose-fermenting, Gram-negative rod [9].
Thus, its role as an important pathogen may be underestimated, but recent
studies showed that Achromobacter spp. may contaminate lenses, lens cases, and
contact lens solutions and subsequently cause corneal inﬁltrative events
(CIEs) [8, 10–12]. Based on a literature, there are 12 reported cases of
A. xylosoxidans keratitis [12]. Infections due to A. xylosoxidans, as a water
pathogen, are associated with humidiﬁers and disinfectants in hospitals, but
contaminated hands can also spread the bacterium to the CL, lens solution, and
lens case [8, 12, 13]. Also, a study using scanning electron microscopy (SEM)
showed that Achromobacter spp. were able to form bioﬁlms on the surface of
CL from patients with microbial keratitis [8]. To the best of our knowledge, there
is no data describing the occurrence of A. xylosoxidans as a causative agent
of contact lens-associated keratitis as well as a contaminant of contact lens cases
in Serbia.
The aim of this study was to investigate the possibility of isolated strain
of A. xylosoxidans from contact lens case to form bioﬁlm on the surface of
soft contact lens, to quantify the production of the formed bioﬁlm, and
compare it with the reference strains (P. aeruginosa, S. aureus, andHaemophilus
inﬂuenzae).
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Materials and Methods
Bacterial strain
Samples from 71 contact lens cases used by asymptomatic contact lens
wearers were streaked onto Columbia agar plate (Torlak, Serbia) containing
5% sheep blood and MacConkey agar plate (HiMedia, India). After incubation
at 37 °C for 24 h, the colonies were identiﬁed by automated Vitek2 System
(bioMérieux, France) using GN card. The strain from one contact lens case was
identiﬁed as A. xylosoxidans.
Bioﬁlm assay
In order to detect, quantify, and compare the production of bioﬁlm on soft
CL (Air Optix, Alcon, USA) by isolated strain of A. xylosoxidans, reference strains
P. aeruginosa ATCC 27853, S. aureus ATCC 29213, and H. inﬂuenzae ATCC
49766 were also analyzed. Bacterial suspensions of tested strains were prepared in
sterile saline and adjusted to the density of 0.5 McFarland standard.
CL were placed in separate wells of 24-well microtitre plates (Sarstedt) with
1,800 μL of tryptic soy broth (bioMérieux) supplemented with additional 1%
glucose. Two hundred microliters of previously prepared bacterial suspension of
analyzed strains were added to each well. Negative control for each plate
represented only the medium with and without CL. After 24 h of incubation at
35 °C in aerobic conditions, plates with CL were decanted and rinsed gently three
times with 2,000 μL of sterile phosphate-buffered saline (pH 7.2) in order to
remove planktonic bacteria. After air drying, plates with CL were ﬁxed with
2,000 μLmethanol per well for 20 min, dried and stained with 2,000 μL per well of
2% crystal violet (bioMérieux) for 15 min. Unbounded dye was rinsed with water.
After air drying, CL were transferred into new 24-well microtitre plates and dye
bound to bioﬁlm formed on CL was released with 2,000 μL of 96% ethanol per
well for 20 min at room temperature, with gentle tapping. Extracted dye was
transferred to 96-well microtitre plates (150 μL per well) and optical density (OD)
was measured at 570 nm using a microtitre plate reader (ICN Flow Titertek
Multiscan Plus, Germany). The results were calculated according to Stepanovic´
et al. [14]. Each assay was repeated three times on three consecutive days. OD
value of negative control (CL cultivated in medium without bacteria) was
subtracted from measured OD values of all tested strains and mean OD values
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from three experiments were calculated. To calculate the category of bioﬁlm
production, the cut-off optical density (ODc) was determined as three standard
deviations above the mean OD of the negative control. According to the obtained
results all tested strains were divided into four groups: OD ≤ODc – category 0 (no
bioﬁlm producer); ODc<OD ≤ 2×ODc – category 1 (weak bioﬁlm producer, +);
2×ODc<OD ≤ 4×ODc – category 2 (moderate bioﬁlm producer, ++); 4×ODc<
OD – category 3 (strong bioﬁlm producer, +++).
Results
Bacterial strain isolated from one of 71 contact lens cases was identiﬁed as
A. xylosoxidans. We examined if isolated strain of A. xylosoxidans was capable to
produce bioﬁlm on soft CL. Quantiﬁcation of bioﬁlm production on soft CL by
isolated strain of A. xylosoxidans compared with reference strains is presented in
Table I and Figure 1.
Discussion
We investigated the possibility of isolated strain of A. xylosoxidans from
contact lens case to form bioﬁlm on the surface of soft CL. We found that the
examined strain was able to produce bioﬁlm on contact lens.
Kilvington et al. [11] showed the ability of Achromobacter spp. to survive
within dry storage cases and assumed it was related to protection gained from
bioﬁlm formation.
Study using culture-independent methods found that Achromobacter spp.
was predominant bacterium in patients with contact lens-related corneal disease,
with occurrence of 76% of lens cases. This outcome was in part explained by the
Table I. Category of bioﬁlm production by isolated and reference strains
Strains Category
Achromobacter xylosoxidans +++
Pseudomonas aeruginosa ATCC 27853 ++
Staphylococcus aureus ATCC 29213 ++
Haemophilus inﬂuenzae ATCC 49766 ++
Sterile lens 0
Note:+++, category 3 – strong bioﬁlm producer; ++, category 2 –moderate bioﬁlm producer; 0, category 0 –
no bioﬁlm producer.
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ability of Achromobacter to form bioﬁlms on the surface of CL, which was
conﬁrmed by SEM analysis [8].
Some studies showed that Achromobacter spp. can form bioﬁlm on surfaces
other than CL, such as central venous catheters and urinary catheters [15, 16]. The
presence of bioﬁlms in sputum from cystic ﬁbrosis (CF) patients infected with
A. xylosoxidans was revealed in one study. This study showed that bacterial cells
in A. xylosoxidans bioﬁlms are located very close to each other, unlike bioﬁlms of
P. aeruginosa, where rich extracellular matrix separates bacterial cells [17].
Our study showed that isolated A. xylosoxidans strain was strong bioﬁlm
producer, while reference strains were moderate bioﬁlm producers. Trancassini
et al. [18] showed the ability of A. xylosoxidans isolated from samples of CF and
non-CF patients to form bioﬁlms on abiotic surfaces. According to this study, the
majority of isolated strains (57.9%) were strong bioﬁlm producers, while 26.3%
strains were moderate, and only 12.3% strains were weak bioﬁlm producers [18].
According to Reddy et al. [13] penetrating keratoplasty and topical steroid
use are the main risk factors in A. xylosoxidans ocular infections. However, recent
study where 8 out of 28 patients with A. xylosoxidans keratitis were contact lens
wearers, implicates that contact lens wear may also be an important risk factor
[19]. Three case reports of keratitis and one case report of conjunctivitis caused by
A. xylosoxidans in healthy contact lens wearers were previously described,
Figure 1. Bioﬁlm production of analyzed strains on soft contact lenses. OD, optical density
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pointing out that this organism should be considered as potential pathogen in
contact lens-related ocular infections [10, 12, 20].
A. xylosoxidans is often confused with other Gram-negative rods, which is
the reason why A. xylosoxidans ocular infections are probably underreported [13].
Although A. xylosoxidans is very similar to Pseudomonas, it differs from
Pseudomonas in being less virulent and having different antibiotic resistance
proﬁles and clinical presentation [8, 19].
Since there are difﬁculties in identifying the causative organism in contact
lens-related ocular infections, American Academy of Ophthalmology [21] recom-
mended empiric administration of antibiotics for those infections with no causative
organism identiﬁed. Their recommendations are ﬂuoroquinolones or cefazolin/
tobramycin combination therapy. A study using culture-independent methods,
mentioned above, also explained the prevalence of Achromobacter over
Pseudomonas by the resistance of this organism to empirical antibiotics used in
treatment of corneal infection [8].
A. xylosoxidans should be considered as a potential pathogen in patients
showing Gram-negative bacilli on smear examination who have compromised
ocular status and slowly progressive disease [13].
The international ISO 14729 and FDA 510(k) standards for adequate
antimicrobial efﬁcacy of contact lens multipurpose solutions are based only on
tests which determine the efﬁcacy against reference strains of planktonic bacteria
and fungi (P. aeuruginosa, S. aureus, S. marcescens, Fusarium solani, and
Candida albicans) [22]. Antimicrobial activity against such strains does not
guarantee efﬁcacy against clinical isolates. In one study, Achromobacter spp.
was isolated in the majority (61%) of contact lens cases of contact lens wearers
with CIEs, that all used the same multipurpose disinfecting solution (MPDS). High
levels of contamination were explained by the resistance of isolated strains to the
biocidal components of the used MPDS [11].
A study showing that bacterial bioﬁlms formed on contact lens surfaces are
more resistant to contact lens solutions than planktonic cells, pointed out the
importance of incorporating tests for activity against bioﬁlms and not only against
planktonic cells [7]. Chang et al. [23] found that A. xylosoxidans bioﬁlms were
more resistant to the two common ophthalmic preservatives than bioﬁlms of
P. aeruginosa, and suggested the incorporation of A. xylosoxidans bioﬁlm in
antimicrobial efﬁcacy tests which would improve safety of multiuse ophthalmic
products.
In our study, we have shown that isolated strain of A. xylosoxidans was
capable to form strong bioﬁlm on the surface of soft CL, and that it appears to be
superior bioﬁlm producer relative to reference strains.
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